# Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Presenting With Significant Villous Atrophy in the Small Intestine

**Authors:** Sotaro Ozaka, Haruhiko Takahashi, Tomoe Hamano, Masahide Fukuda, Kazuhiro Mizukami

PMC · DOI: 10.7759/cureus.79496 · 2025-02-23

## TL;DR

A rare intestinal T-cell lymphoma caused significant villous atrophy, highlighting the need for detailed endoscopic and histological evaluation in patients with persistent diarrhea.

## Contribution

This case report highlights MEITL as a potential cause of villous atrophy in the small intestine, emphasizing the importance of magnifying endoscopy and biopsy for diagnosis.

## Key findings

- MEITL can present with significant villous atrophy in the small intestine.
- Magnifying endoscopy and histological examination are crucial for diagnosing MEITL in patients with refractory diarrhea.
- The patient's poor prognosis underscores the aggressive nature of MEITL despite chemotherapy.

## Abstract

Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare and aggressive primary intestinal T-cell lymphoma with a high mortality rate and poor prognosis. Although endoscopy plays a key role in early diagnosis, reports on detailed endoscopic findings are limited. Here, we present a case of MEITL with refractory diarrhea and significant villous atrophy, as observed on endoscopy.

A 67-year-old woman was admitted to our hospital with refractory diarrhea and weight loss. Esophagogastroduodenoscopy revealed microgranular mucosa with significant villous atrophy in the duodenum. Enhanced magnifying endoscopy with narrow band imaging showed flattening and loss pattern of the villi in the transverse part of the duodenum. Colonoscopy also showed significant villous atrophy in the ileum. Biopsy specimens from the duodenum and ileum showed diffuse proliferation of small- to medium-sized atypical lymphoid cells in the lamina propria and intraepithelial lymphocytes. Immunohistochemistry revealed that the cells were positive for CD3, CD8, CD56, and Granzyme B. Diagnosing MEITL, PVPP (sobuzoxane, etoposide, and prednisone) chemotherapy was administered. However, since the patient developed intestinal obstruction after two courses of chemotherapy, it was discontinued. The patient died of intestinal perforation 82 days after diagnosis.

MEITL can cause villous atrophy in the small intestine. Hence, magnifying endoscopy and follow-up histological examination are essential when villous atrophy is observed in patients with refractory diarrhea.

## Linked entities

- **Proteins:** cd.3 (Cd.3 conserved hypothetical protein), CD8A (CD8 subunit alpha), NCAM1 (neural cell adhesion molecule 1)
- **Chemicals:** sobuzoxane (PubChem CID 5233), etoposide (PubChem CID 36462), prednisone (PubChem CID 5865)
- **Diseases:** Monomorphic epitheliotropic intestinal T-cell lymphoma (MONDO:0958096), intestinal obstruction (MONDO:0004565), intestinal perforation (MONDO:0006807)

## Full-text entities

- **Genes:** NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}
- **Diseases:** weight loss (MESH:D015431), Villous Atrophy (MESH:C564019), intestinal obstruction (MESH:D007415), MEITL (MESH:D016399), diarrhea (MESH:D003967), intestinal perforation (MESH:D007416)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11936312/full.md

---
Source: https://tomesphere.com/paper/PMC11936312